Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 82 Records) |
| Query Trace: Adenocarcinoma and STK11[original query] |
|---|
| Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Translational lung cancer research 2021 8 10 (7): 3236-3250. Jiao Xiao-Dong, Ding Li-Ren, Zhang Chuan-Tao, Qin Bao-Dong, Liu Ke, Jiang Lian-Ping, Wang Xi, Lv Li-Ting, Ding Hao, Li Dao-Ming, Yang Hui, Chen Xue-Qin, Zhu Wen-Yu, Wu Ying, Ling Yan, He Xi, Liu Jun, Shao Lin, Wang Hao-Zhe, Chen Yan, Zheng Jing-Jing, Inui Naoki, Zang Yuan-She |
| Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma. Clinical lung cancer 2021 8 23 (2): e137-e139. Pathak Ranjan, Salgia Ra |
| Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Nov . Ricciuti Biagio, Arbour Kathryn C, Lin Jessica J, Vajdi Amir, Vokes Natalie, Hong Lingzhi, Zhang Jianjun, Tolstorukov Michael Y, Li Yvonne Y, Spurr Liam F, Cherniack Andrew D, Recondo Gonzalo, Lamberti Giuseppe, Wang Xinan, Venkatraman Deepti, Alessi Joao V, Vaz Victor R, Rizvi Hira, Egger Jacklynn, Plodkowski Andrew J, Khosrowjerdi Sara, Digumarthy Subba, Park Hyesun, Vaz Nuno, Nishino Mizuki, Sholl Lynette M, Barbie David, Altan Mehmet, Heymach John V, Skoulidis Ferdinandos, Gainor Justin F, Hellmann Matthew D, Awad Mark |
| Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases. Pathology, research and practice 2021 Nov 229 153652. Sun Hui, Li Xiaoli, Zhang Jianguo, Liu Yif |
| Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer prevention research (Philadelphia, Pa.) 2021 Oct . Furniss C Sloane, Yurgelun Matthew B, Ukaegbu Chinedu, Constantinou Pamela E, Lafferty Catherine C, Talcove-Berko Eliana R, Schwartz Alison N, Stopfer Jill E, Underhill-Blazey Meghan, Kenner Barbara, Nelson Scott H, Okumura Sydney, Law Sherman, Zhou Alicia Y, Coffin Tara B, Rodriguez Nicolette J, Uno Hajime, Ocean Allyson J, McAllister Florencia, Lowy Andrew M, Lippman Scott M, Klein Alison P, Madlensky Lisa, Petersen Gloria M, Garber Judy E, Goggins Michael G, Maitra Anirban, Syngal Sap |
| Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC. JTO clinical and research reports 2022 Sep 3 (9): 100390. Cooper Alissa J, Muzikansky Alona, Lennerz Jochen, Narinesingh Farhaana, Mino-Kenudson Mari, Hung Yin P, Piotrowska Zofia, Dagogo-Jack Ibiayi, Sequist Lecia V, Gainor Justin F, Lin Jessica J, Heist Rebecca |
| Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2022 6 22 (6): 760-769. Peters Mary Linton B, Eckel Andrew, Lietz Anna, Seguin Claudia, Mueller Peter, Hur Chin, Pandharipande Pari |
| Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer? Journal of the National Comprehensive Cancer Network : JNCCN 2022 6 20 (6): 663-673.e12. Wang Yifan, Cuggia Adeline, Chen Yen-I, Parent Josée, Stanek Agatha, Denroche Robert E, Zhang Amy, Grant Robert C, Domecq Céline, Golesworthy Bryn, Shwaartz Chaya, Borgida Ayelet, Holter Spring, Wilson Julie M, Chong George, O'Kane Grainne M, Knox Jennifer J, Fischer Sandra E, Gallinger Steven, Gao Zu-Hua, Foulkes William D, Waschke Kevin A, Zogopoulos Geor |
| Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer. Cell metabolism 2022 5 34 (6): 874-887.e6. Best Sarah A, Gubser Patrick M, Sethumadhavan Shalini, Kersbergen Ariena, Negrón Abril Yashira L, Goldford Joshua, Sellers Katherine, Abeysekera Waruni, Garnham Alexandra L, McDonald Jackson A, Weeden Clare E, Anderson Dovile, Pirman David, Roddy Thomas P, Creek Darren J, Kallies Axel, Kingsbury Gillian, Sutherland Kate |
| Next-Generation Sequencing in Lung Cancer Patients: A Comparative Approach in NSCLC and SCLC Mutational Landscapes. Journal of personalized medicine 2022 3 12 (3): . Pop-Bica Cecilia, Ciocan Cristina Alexandra, Braicu Cornelia, Harangu? Antonia, Simon Marioara, Nutu Andreea, Pop Laura Ancuta, Slaby Ondrej, Atanasov Atanas G, Pirlog Radu, Al Hajjar Nadim, Berindan-Neagoe Ioa |
| Mutational status of main driver genes influences the prognosis of stage I-III lung adenocarcinoma patients underwent radical surgery. Translational cancer research 2021 Jul 10 (7): 3286-3298. Liao Hongliang, Luo Xiaoyan, Liang Yaqin, Wan Renping, Xu Me |
| Dual Checkpoint Inhibition: An Approach for STK11 and KRAS Co-Mutated Lung Adenocarcinoma? JCO precision oncology 2022 2 3 1-3. Stein Matthew K, Prouet Philippe, Martin Michael |
| Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology 2022 12 . Scalera S, Ricciuti B, Mazzotta M, Calonaci N, Alessi J V, Cipriani L, Bon G, Messina B, Lamberti G, Di Federico A, Pecci F, Milite S, Krasniqi E, Barba M, Vici P, Vecchione A, De Nicola F, Ciuffreda L, Goeman F, Fanciulli M, Buglioni S, Pescarmona E, Sharma B, Felt K D, Lindsay J, Rodig S J, De Maria R, Caravagna G, Cappuzzo F, Ciliberto G, Awad M M, Maugeri-Saccà |
| Genomic landscape of lung adenocarcinomas in different races. Frontiers in oncology 2022 12 946625. Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany |
| Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/LKB1 Mutation. JCO precision oncology 2022 1 4 1239-1245. Nadal Ernest, Heeke Simon, Benzaquen Jonathan, Vilariño Noelia, Navarro Arturo, Azuara Daniel, Varela Mar, Otto Josiane, Baixeras Nuria, Shahbazian David, Puchois Pascal, Church Sarah E, Smith Thomas H, Lanteri Elisabeth, Ilié Marius, Hofman Pa |
| The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer. Gynecologic oncology 2023 6 175 133-141. Jin Li, Xiaohong Xue, Yan Zhang, Fengna Ding, Wenyan Wu, Cuicui Liu, Yang Xu, Hanlin Chen, Qiuxiang Ou, Yang Shao, Xinjun Li, Fei Wu, Xiaohua |
| Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Molecular genetics & genomic medicine 2023 3 e2170. Jiang Huiqin, Huang Fei, Chen Xinning, Zhang Li, Shen Minna, Pan Baishen, Wang Beili, Guo W |
| [Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 2 52 (2): 117-123. Guo L Y, Xiang C, Zhao R Y, Chen S N, Ma S J, Han Y |
| Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of cancer research and clinical oncology 2024 9 150 (9): 413. Guomin Gu, Chunling Liu, Xiaodan Zhu, Yan Yang, Shuming Song, Yan Zhao, Gang S |
| Dissecting the clinicopathological, genomic, and prognostic significance of ALK rearrangement in resected lung adenocarcinoma. The Journal of thoracic and cardiovascular surgery 2024 9 . Hang Cao, Wangyang Zhu, Huatao Tang, Chaoqiang Deng, Fangqiu Fu, Yuan Li, Yang Zhang, Haiquan Ch |
| Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions. Cancer cytopathology 2024 8 . Cristiana M Pineda, Adnan Majid, Daniel B Costa, Paul A VanderLa |
| TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
| Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma. PloS one 2024 7 19 (7): e0307580. Yao Liang, Osamu Maeda, Chiaki Kondo, Kazuki Nishida, Yuichi An |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. Therapeutic advances in medical oncology 2024 5 16 17588359241253113. Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P Thomas, Susan Tsai, Kathleen K Christians, Douglas B Evans, Callisia N Clarke, William A Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamg |
| Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer. Frontiers in immunology 2024 5 15 1387896. Jianqing Zheng, Yujie Deng, Bifen Huang, Xiaohui Ch |
| Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration. Frontiers in immunology 2024 12 15 1485358. Du Feng, Huixin Jiang, Gengjia Chen, Wenhui Guan, Lin Yi, Yue Zhu, Yijia Li, Gengda Huang, Bin He, Junlong Tang, Yujie Tang, Jiyuan Zeng, Wensheng Zhou, Jiayu Shi, Zhanhong Xie, Ming Liu, Xiaohong Xie, Xinqing Lin, Chengzhi Zh |
| Putative mechanisms of primary resistance to EGFR-targeted therapies: A retrospective study. Lung cancer (Amsterdam, Netherlands) 2024 11 197 107998. Xueliang Tu, Zhongyu Lu, Fengrong Hei, Tong Zhang, Xiaoxuan Wang, Dongsheng Chen, Fengjuan Fan, Jing Xu, Xing Zhang, Kefeng G |
| Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction. Cancers 2024 1 16 (1): . Dimitrios C Ziogas, Eirini Papadopoulou, Helen Gogas, Stratigoula Sakellariou, Evangellos Felekouras, Charalampos Theocharopoulos, Dimitra T Stefanou, Maria Theochari, Ioannis Boukovinas, Dimitris Matthaios, Anna Koumarianou, Eleni Zairi, Michalis Liontos, Konstantinos Koutsoukos, Vasiliki Metaxa-Mariatou, George Kapetsis, Angeliki Meintani, Georgios N Tsaousis, George Nasioul |
| Comprehensive analysis of genomic alterations and novel prognostic biomarkers, and establishment of prediction models of metastasis in metastatic non-small cell lung cancer. Journal of Cancer 2025 1 16 (1): 339-350. Kangwei Wang, Meifeng Ye, Zexun Mo, Xiaomei Huang, Yujun Li, Shuquan W |
- Page last reviewed:Feb 1, 2024
- Content source: